If we can get a clear understanding and a reasonable pathway [from the Food and Drug Administration], then we have the end in sight.
Mount Laurel, NJ (PRWEB) October 07, 2011
DiabetesCare.net announces the publication of part one of a two-part interview series titled “The Artificial Pancreas: Where Are We Now?” with the JDRF’s Aaron Kowalski, PhD, assistant vice president of Treatment Therapies, and the point person for the Artificial Pancreas Research project.
There is a tremendous amount of excitement surrounding the possibility of this technology and its hope to help people with insulin-dependent diabetes. This type of diabetes primarily affects people with type 1 diabetes, but some people with type 2 diabetes also take insulin to manage their conditions. According to JDRF, as many as 3 million Americans may have type 1 diabetes, and more than 15,000 children and 15,000 adults are diagnosed with type 1 diabetes every year.
While there is hope for what this technology promises, not a lot of in-depth information is known or understood about the overall project, and what it is going to take to bring the technology to market. In the two-part interview, Dr. Kowalski lays out where the project is today; what JDRF’s expectations for the technology will be; the challenges and roadblocks that remain; and when Americans can possibly expect to see the first phase of the artificial pancreas on the market.
“If we can get a clear understanding and a reasonable pathway [from the Food and Drug Administration], then we have the end in sight,” explains Dr. Kowalski of the expectations for when Americans might see the first phase of the artificial pancreas on the market. “The devices exist, the algorithms exist, and it is a matter of testing them. The preliminary tests have all been great. It is not 10 years from now. If you are a company, this is commercial development time… I would be very disappointed if people aren’t using these systems in 2015―and I hope it is sooner.”
Along with discussing a possible timeline for the artificial pancreas, Dr. Kowalski lays out the three evolutionary phases in creating a closed loop artificial pancreas, and what treatment results each phase will deliver to people with insulin-dependent diabetes.
“What we have tried to do is create our “closing the loop” roadmap,” explains Dr. Kowalski. “This includes steps where we think some mechanical approaches could be developed that would be meaningful both clinically and to patients in the near term while we drive towards a very sophisticated hormone-driven artificial pancreas.”
Part one of this interview can be found here, in the DiabetesCare.net’s new healthcare “Provider”section of the website.
In the coming months, DiabetesCare.net’s new healthcare Providers’ section will continue to provide information about this important technology, including interviews with leading researchers, updates on the pending FDA guidance in December, and insights from artificial pancreas manufacturers explaining how their devices work.
In addition to being at the forefront of groundbreaking stories such as the artificial pancreas, DiabetesCare.net continues to be a resource for both people with diabetes and the healthcare providers who care for them.
DiabetesCare.net also maintains interactive lifestyle tracking tools on the website that allows anyone with diabetes access to features they can utilize anytime, including a Nutrition Tracker, Blood Glucose Tracker, A1C Converter, Exercise Tracker, and our new Carb Planning Tool, to name a few. People have the ability to not only track the carbohydrates in a given food, they can meal plan, and keep a caloric database, which they can then send as reports to their diabetes educator ahead of scheduled appointments.
To learn more about the healthcare Providers’ section of the DiabetesCare.net website, contact Clinical Content Coordinator John Parkinson by phone at: (866) 593-6637 or by e-mail at: jparkinson(at)diabetescare(dot)net
About DiabetesCare.net: Launched on Feb. 1, 2010, DiabetesCare.net is a one-stop Internet destination with the sole purpose of helping people learn the latest news and trends to help themselves, a loved one, or a friend manage their diabetes, or for those at risk, prevent occurrence of the disease.
# # #